Results 101 to 106 of about 558 (106)

One test to identify 50% of all Norwegian BRCA1 mutations [PDF]

Dahlberg, OJ, Hagen, A, Hagen, B, Heimdal, K, Hovig, E, Lycke, K, Løvslett, K, Møller, P, Qvist, H, Stacy, RAP   +9 more
core   +2 more sources

Other cancers in BRCA1 and BRCA2 mutation carriers: implications for counselling and follow up [PDF]

Ponder, B
core   +2 more sources

Some of the next articles are maybe not open access.

Related searches:

Circulating IGF-1, IGFB-3, GH and TSH levels in multiple sclerosis and their relationship with treatment

Neurological Research, 2017
Improving the proficiency of oligodendrocytes in their ability to repair myelin damage is one of the major goals of multiple sclerosis treatment. Insulin-like growth factor-1 (IGF-1) is one of several polypeptides that are considered to have potential benefits in that sense.
Aylin, Akcali, Berrin, Bal, Binnur, Erbagci   +2 more
openaire   +2 more sources

The acute effect of dexamethasone on plasma leptin concentrations and the relationships between fasting leptin, the IGF‐I/IGFBP system, dehydroepiandrosterone, androstenedione and testosterone in an elderly population

Clinical Endocrinology, 1998
OBJECTIVETo investigate the acute effect of dexamethasone administration on serum leptin levels and the relationships between dehydroepiandrosterone (DHEAS), androstenedione, testosterone and the IGF‐I/IGFBP system and leptin levels in healthy elderly humans.METHODSIn 209 healthy elderly individuals (95 men, 114 women, aged 55–80 years) measurements ...
Janssen, J.A.M.J.L., Huizenga, N.A.T.M., Stolk, R.P., Grobbee, D.E., Pols, H.A.P., de Jong, F.H., Attanasio, A.M.F., Blum, W.F., Lamberts, S.W.J.   +8 more
openaire   +4 more sources

Insulin-like growth factor I (IGF-I) receptors on blood cells: their relationship to circulating total and "free" IGF-1, IGFB-1, IGFBP-3 and insulin levels in healthy subjects

Growth Hormone and IGF Research, 1997
Janssen, J.A.M.J.L., Uitterlinden, Piet, Hofland, Leo, Lamberts, S.W.J.   +3 more
openaire   +1 more source

Collaboration to identify certain lead antisense inhibitor compounds (oligonucleotides) using MOE chemistry with exclusive and nonexclusive patent, process and technology license to develop, make, have made, use, sell, have sold, offer, import and sublicense pharmaceutical preparations comprising a single antisense inhibitor which down regulates the genes IGFB-5 (Insulin-like Growth Factor Binding Protein) and/or IGFBP-2.

2006
openaire   +1 more source